Insider’s View: Deciphering Dexcom Inc (DXCM)’s Financial Health Through Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Dexcom Inc (NASDAQ: DXCM) closed at $74.46 in the last session, down -1.04% from day before closing price of $75.24. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 3.23 million shares were traded. DXCM stock price reached its highest trading level at $75.76 during the session, while it also had its lowest trading level at $74.14.

Ratios:

We take a closer look at DXCM’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.36. For the most recent quarter (mrq), Quick Ratio is recorded 2.12 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.30.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on July 26, 2024, Downgraded its rating to Neutral and sets its target price to $80 from $161 previously.

On July 26, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $145 to $75.

On May 30, 2024, Redburn Atlantic started tracking the stock assigning a Neutral rating and target price of $130.Redburn Atlantic initiated its Neutral rating on May 30, 2024, with a $130 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when Sylvain Jereme M sold 3,500 shares for $75.51 per share. The transaction valued at 264,285 led to the insider holds 80,774 shares of the business.

JEREME SYLVAIN bought 3,500 shares of DXCM for $264,285 on Nov 15 ’24. On Sep 16 ’24, another insider, Heller Bridgette P, who serves as the Director of the company, sold 1,000 shares for $70.00 each. As a result, the insider received 70,000 and left with 24,349 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DXCM now has a Market Capitalization of 29083703296 and an Enterprise Value of 29182631936. As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.63, and their Forward P/E ratio for the next fiscal year is 36.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.36 while its Price-to-Book (P/B) ratio in mrq is 14.70. Its current Enterprise Value per Revenue stands at 7.381 whereas that against EBITDA is 34.725.

Stock Price History:

Over the past 52 weeks, DXCM has reached a high of $142.00, while it has fallen to a 52-week low of $62.34. The 50-Day Moving Average of the stock is 5.56%, while the 200-Day Moving Average is calculated to be -26.78%.

Shares Statistics:

According to the various share statistics, DXCM traded on average about 4.29M shares per day over the past 3-months and 4371890 shares per day over the past 10 days. A total of 390.60M shares are outstanding, with a floating share count of 385.54M. Insiders hold about 1.29% of the company’s shares, while institutions hold 93.16% stake in the company. Shares short for DXCM as of 1730332800 were 9362381 with a Short Ratio of 2.18, compared to 1727654400 on 9554763. Therefore, it implies a Short% of Shares Outstanding of 9362381 and a Short% of Float of 2.71.

Most Popular